Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Placenta|August 17, 2023
Preeclampsia to COVID-19: A journey towards improved placental and vascular function using sulforaphaneNeville J Fields, Kirsten R Palmer, Anthony Nisi, et al.
Journal of Pain and Symptom Management|January 3, 2017
Longitudinal Examination of Symptom Profiles Among Breast Cancer SurvivorsNancy E Avis, Beverly Levine, Sarah A Marshall, et al.
Expert Opinion on Pharmacotherapy|February 2, 2019
Current and emerging pharmacotherapy for emergency management of preeclampsiaAnnie G Cox, Sarah A Marshall, Kirsten R Palmer, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|July 2, 2016
The Role of Relaxin in Normal and Abnormal Uterine Function During the Menstrual Cycle and Early PregnancySarah A Marshall, Sevvandi N Senadheera, Laura J Parry, et al.
Placenta|January 19, 2022
Silencing of Nrf genes in the human placenta as measured by SDS-PAGE and Western Blotting techniquesYann W Yap, Natalie J Hannan, Euan M Wallace, et al.
Pregnancy Hypertension|March 22, 2026
Calcineurin inhibitors and the risk of preeclampsia in solid organ transplantation - Should we rethink our approach during pregnancy?Jennifer H Yo, Kirsten R Palmer, Sarah A Marshall, et al.
Microcirculation (New York, N.Y. : 1994)|December 18, 2018
Targeting the vascular dysfunction: Potential treatments for preeclampsiaSarah A Marshall, Annie G Cox, Laura J Parry, et al.
Microcirculation (New York, N.Y. : 1994)|June 8, 2018
From pregnancy to cardiovascular disease: Lessons from relaxin-deficient animals to understand relaxin actions in the vascular systemMaria Jelinic, Sarah A Marshall, Chen H Leo, et al.
Reproduction (Cambridge, England)|January 17, 2022
Activin A causes endothelial dysfunction of mouse aorta and human aortic cellsCourtney Barber, Yann Yap, Natalie J Hannan, et al.
Pageof 5